PuSH - Publikationsserver des Helmholtz Zentrums München

Zeitschriften-Browsing

117 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
Alle Publikationen dieser Seite in den Korb legen
61.
Winkler, C. et al.: Age, HLA, and sex define a marked risk of organ-specific autoimmunity in first-degree relatives of patients with type 1 diabetes. Diabetes Care 42, 1684-1691 (2019)
62.
Andersen, S.T.* et al.: Risk factors for incident diabetic polyneuropathy in a cohort with screen-detected type 2 diabetes followed for 13 years: Addition-Denmark. Diabetes Care 41, 1068-1075 (2018)
63.
Auzanneau, M.* et al.: Area deprivation and regional disparities in treatment and outcome quality of 29,284 pediatric patients with type 1 diabetes in Germany: A cross-sectional multicenter DPV analysis. Diabetes Care 41, 2517-2525 (2018)
64.
Frank-Podlech, S. et al.: Leptin replacement reestablishes brain insulin action in the hypothalamus in congenital leptin deficiency. Diabetes Care 41, 907-910 (2018)
65.
Kähm, K. et al.: Health care costs associated with incident complications in patients with type 2 diabetes in Germany. Diabetes Care 41, 971-978 (2018)
66.
Uusitalo, U.* et al.: Early infant diet and islet autoimmunity in the TEDDY Study. Diabetes Care 41, 522-530 (2018)
67.
Herder, C.* et al.: Proinflammatory cytokines predict the incidence and progression of distal sensorimotor polyneuropathy: KORA F4/FF4 Study. Diabetes Care 40, 569-576 (2017)
68.
TEDDY Study Group (Hummel, S. ; Beyerlein, A. ; Ziegler, A.-G.) et al.: First infant formula type and risk of islet autoimmunity in the environmental determinants of diabetes in the young (TEDDY) study. Diabetes Care 40, 398-404 (2017)
69.
Johnson, S.B.* ; Lynch, K.F.* ; TEDDY Study Group (Roth, R.) & Schatz, D.*: My child is islet autoantibody positive: Impact on parental anxiety. Diabetes Care 40, 1167-1172 (2017)
70.
Kollerits, B.* et al.: Plasma concentrations of afamin are associated with prevalent and incident type 2 diabetes: A pooled analysis in more than 20,000 individuals. Diabetes Care 40, 1386-1393 (2017)
71.
Krischer, J.P.* et al.: Genetic and environmental interactions modify the risk of diabetes-related autoimmunity by 6 years of age: The TEDDY Study. Diabetes Care 40, 1194-1202 (2017)
72.
Frank, S.* et al.: Neuronal food reward activity in patients with type 2 diabetes with improved glycemic control after bariatric surgery. Diabetes Care 39, 1311-1317 (2016)
73.
Jordan, J.* ; El-Armouche, A.* ; Hanefeld, M.* ; Bornstein, S.R. & Birkenfeld, A.L.: CV Protection in the EMPA-REG OUTCOME Trial: A "Thrifty Substrate" Hypothesis. Diabetes Care 2016;39:1108-1114. Diabetes Care 39, E224-E225 (2016)
74.
Vehik, K.* et al.: Reversion of β-cell autoimmunity changes risk of type 1 diabetes: TEDDY study. Diabetes Care 39, 1535-1542 (2016)
75.
Bonifacio, E.: Predicting type 1 diabetes using biomarkers. Diabetes Care 38, 989-996 (2015)
76.
Brandmaier, S. et al.: Response to Comment on Xu et al. Effects of metformin on metabolite profiles and LDL cholesterol in patients with type 2 diabetes. Diabetes Care 2015;38:1858-1867. Diabetes Care 38, e216-e217 (2015)
77.
Herder, C.* et al.: Differential association between biomarkers of subclinical inflammation and painful polyneuropathy: Results from the KORA F4 study. Diabetes Care 38, 91-96 (2015)
78.
Insel, R.A.* et al.: Staging presymptomatic type 1 diabetes: A scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association. Diabetes Care 38, 1964-1974 (2015)
79.
Kemppainen, K.M.* et al.: Early childhood gut microbiomes show strong geographic differences among subjects at high risk for type 1 diabetes. Diabetes Care 38, 329-332 (2015)
80.
Kullmann, S. et al.: Selective insulin resistance in homeostatic and cognitive control brain areas in overweight and obese adults. Diabetes Care 38, 1044-1050 (2015)